The stubborn symptoms of onychomycosis can take down even the tough guys. ONMEL® (itraconazole) effectively treats toenail fungus at its source.1 Just one pill a day for 12 weeks
helps your patients kick onychomycosis1—and
get back in the game.
Onychomycosis can hammer your toenails. ONMEL® (itraconazole) utilizes proprietary Meltrex® Technology and helps stop the infection where it starts.2 ONMEL helps you goto work
on toenail fungus.1
Onychomycosis can trip up even the most well-heeled professional. Stubborn symptoms of nail fungus can become embarrassing and tough to handle.3 ONMEL® (itraconazole) provides the
power of itraconazole with once-daily, 12-week
dosing.1 Help your patients kick onychomycosis
and get back to business.
One ONMEL tablet has efficacy comparable to two 100-mg, once-daily itraconazole capsules.1,5
Take a look at the results from a large-scale, randomized controlled trial for onychomycosis.
Melt-extrusion technology allows for 200 mg of itraconazole in a single tablet. This dosing provides:
Eligible patients can receive great savings on their ONMEL prescriptions at participating pharmacies. Please see full terms and conditions on savings offer printout.
ONMEL is a prescription medicine used to treat fungal infections of the toenails.
It is not known if ONMEL is safe and effective in children under the age of 18.
ONMEL can cause serious life-threatening side effects, including:
1. Heart Failure. Do not take ONMEL if you have had heart failure, including congestive heart failure. Stop taking ONMEL and call your doctor right away if you have any of these symptoms of congestive heart failure:
2. Serious cardiovascular effects. Do not take ONMEL if you also take the following medicines:
Do not take ONMEL if you:
ONMEL can cause serious side effects, including:
These are not all of the possible side effects of ONMEL. Tell your doctor if you have any side effect that bothers you or that does not go away. For more information, ask your doctor.
Sebela is committed to advancing treatment in antifungal therapy.
For other information, please contact:
Sebela Pharmaceuticals Inc.
645 Hembree Parkway, Suite I
Roswell, GA 30076
Toll free: 844-SEBELA1
You can also view our Privacy & Usage Policy for this website.
References: 1. ONMEL [package insert]. Greensboro, NC: Merz Pharmaceuticals, LLC; 2012. 2. Data on file. Roswell, GA. Sebela Pharmaceuticals Inc. 3. Rodgers P, Bassler M. Treating onychomycosis. Am Fam Physician. 2001;63:663-672. 4. Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm. 2002;54(2):107-117. 5. Maddin S, Quiring J, Bulger L. Randomized, placebo-controlled, phase 3 study of itraconazole for the treatment of oncyhomycosis. J Drugs Dermatol. 2013;12(7):758-763.